Environmental and chemical carcinogenesis.

[1]  W. Walker,et al.  The Liver: An Integral Part of the Enteric Mucosal Immune System , 2007, Hepatology.

[2]  A. Conney.  Induction of drug-metabolizing enzymes: a path to the discovery of multiple cytochromes P450. , 2003, Annual review of pharmacology and toxicology.

[3]  Stephen S. Hecht,et al.  Tobacco carcinogens, their biomarkers and tobacco-induced cancer , 2003, Nature Reviews Cancer.

[4]  G. Beck,et al.  Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial. , 2003, Journal of the National Cancer Institute.

[5]  R. Goldsby,et al.  High incidence of epithelial cancers in mice deficient for DNA polymerase δ proofreading , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Hecht,et al.  Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. , 2002, Carcinogenesis.

[7]  J. Stringer,et al.  Embryonic stem cells and somatic cells differ in mutation frequency and type , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Giovanni Parmigiani,et al.  Prevalence of somatic alterations in the colorectal cancer cell genome , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Jackson,et al.  The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. , 2001, Mutation research.

[10]  L. Loeb,et al.  A mutator phenotype in cancer. , 2001, Cancer research.

[11]  M. Ingelman-Sundberg.  Implications of polymorphic cytochrome p450-dependent drug metabolism for drug development. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[12]  Richard D. Wood,et al.  Human DNA Repair Genes , 2001, Science.

[13]  M. Gail,et al.  Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1 , 1999, Hepatology.

[14]  S. Hecht,et al.  Tobacco smoke carcinogens and lung cancer. , 1999, Journal of the National Cancer Institute.

[15]  M. Speicher,et al.  Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Muñoz,et al.  Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. , 1999, Journal of the National Cancer Institute.

[17]  P. Duesberg,et al.  Genetic instability of cancer cells is proportional to their degree of aneuploidy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Hecht,et al.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.

[19]  Y. Lou,et al.  Some Perspectives on Dietary Inhibition of Carcinogenesis: Studies with Curcumin and Tea , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[20]  M. Perucho.  Cancer of the microsatellite mutator phenotype. , 1996, Biological chemistry.

[21]  Chien-Jen Chen,et al.  Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan , 1996, International journal of cancer.

[22]  W C Willett,et al.  The causes and prevention of cancer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[24]  M. Kew,et al.  Hepatitis viruses and hepatocellular carcinoma. , 1994, Research in virology.

[25]  J Piper,et al.  Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Lindahl.  Instability and decay of the primary structure of DNA , 1993, Nature.

[27]  G. Wogan.  Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research. , 1992, Environmental health perspectives.

[28]  B. Henderson,et al.  Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma , 1992, The Lancet.

[29]  G. Wogan.  Aflatoxins as risk factors for hepatocellular carcinoma in humans. , 1992, Cancer research.

[30]  L. Loeb,et al.  Endogenous carcinogenesis: molecular oncology into the twenty-first century--presidential address. , 1989, Cancer research.

[31]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[32]  S. Hecht,et al.  Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. , 1988, Carcinogenesis.

[33]  M. Huang,et al.  Stimulatory effect of 1 alpha, 25-dihydroxyvitamin D3 on the formation of skin tumors in mice treated chronically with 7,12-dimethylbenz[a]anthracene. , 1985, Biochemical and biophysical research communications.

[34]  M. Huang,et al.  1 alpha, 25-Dihydroxyvitamin D3 inhibits phorbol ester-dependent chemical carcinogenesis in mouse skin. , 1983, Biochemical and biophysical research communications.

[35]  G. Grimmer,et al.  Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polycyclic aromatic hydrocarbons. , 1983, Journal of the National Cancer Institute.

[36]  A. Conney,et al.  Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. , 1982, Cancer research.

[37]  E. Glover,et al.  Tumour promotion by TCDD in skin of HRS/J hairless mice , 1982, Nature.

[38]  A. Verma,et al.  Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen. , 1982, Cancer research.

[39]  Harvey Rg.  Polycyclic hydrocarbons and cancer. , 1982 .

[40]  A. Verma,et al.  Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion. , 1979, Cancer research.

[41]  C. Wade,et al.  Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. , 1978, Toxicology and applied pharmacology.

[42]  L. Loeb,et al.  Errors in DNA replication as a basis of malignant changes. , 1974, Cancer research.

[43]  N. Sládek,et al.  Induction of drug metabolism. I. Differences in the mechanisms by which polycyclic hydrocarbons and phenobarbital produce their inductive effects on microsomal N-demethylating systems. , 1969, Molecular pharmacology.

[44]  D. Rall,et al.  ACTIVATION AND DETOXIFICATION OF N-2-FLUORENYLACETAMIDE IN MAN. , 1964, Cancer research.

[45]  J. Miller,et al.  On the protective action of certain polycyclic aromatic hydrocarbons against carcinogenesis by aminoazo dyes and 2-acetylaminofluorene. , 1958, Cancer research.

[46]  J. Miller,et al.  The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. , 1956, Cancer research.

[47]  H. Richardson,et al.  Liver tumor inhibition and adrenal histologic responses in rats to which 3'-methyl-4-dimethylaminoazobenzene and 20-methylcholanthrene were simultaneously administered. , 1952, Cancer research.

[48]  A. Knudson.  Hereditary cancer: Two hits revisited , 2005, Journal of Cancer Research and Clinical Oncology.

[49]  E. Riboli,et al.  Some Naturally Occurring Substances : Food Items and Constituents , Heterocyclic Aromatic Amines and Mycotoxins , 2005 .

[50]  WORLD HEALTH ORGANIZATION INTERNATIONAL AGENCY FOR RESEARCH ON CANCER IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 2003 .

[51]  R. Goldsby,et al.  High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Groopman,et al.  The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight? , 1999, Carcinogenesis.

[53]  Ian Tomlinson,et al.  Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog , 1999, Nature medicine.

[54]  G. Omenn.  Chemoprevention of lung cancer: the rise and demise of beta-carotene. , 1998, Annual review of public health.

[55]  B. Henderson,et al.  A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[56]  D. Bleyl,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs vol. 1 to 42. Supplement 7. 440 Seiten. International Agency for Research on Cancer, Lyon 1987. Preis: 65, – s.Fr , 1989 .

[57]  F. X. Bosch,et al.  Prospects for epidemiological studies on hepatocellular cancer as a model for assessing viral and chemical interactions. , 1988, IARC scientific publications.

[58]  A. Bjørseth,et al.  Polynuclear aromatic hydrocarbons: chemistry and biological effects. [Lead abstract] , 1980 .

[59]  Peter W. Jones,et al.  Polynuclear Aromatic Hydrocarbons , 1979 .

[60]  B. L. Van Duuren.  Tobacco carcinogenesis. , 1968, Cancer research.

[61]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.